Get started
Live feed
·
INSIDERFilingvia Quantisnow
Alimera Sciences Inc. logo

Alimera Sciences (ALIM) executive Holland received 100,000 units

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

David Holland (executive at Alimera Sciences Inc., ALIM) reported that they received 100,000 units on Nov 21, 2023.

Reporting person
Holland David

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Nov 21, 2023Grant or award (A)Employee Stock Option (Right to Buy)On 100,000 Common Stock1+100,000--100,000 direct

Holdings before and after

  • Employee Stock Option (Right to Buy): 0 to 100,000 direct

Other positions listed

  • Common Stock: 109,880 direct

Footnotes from the filing

  1. 1. The employee stock option shall vest as follows: one-fourth of the shares shall vest on November 21, 2024, with the remaining shares vesting in equal monthly installments beginning on December 21, 2024, subject to reporting person's continuous employment.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Holland report in this ALIM Form 4?

David Holland (executive at Alimera Sciences Inc., ALIM) reported that they received 100,000 units on Nov 21, 2023.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for ALIM

Earlier insider filings at ALIM

Quantisnow market dataNASDAQ
Alimera Sciences Inc. logo
ALIM
Alimera Sciences Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2010
Get push alerts for ALIM

Follow ALIM and get a push notification the moment its next story breaks.

Full ALIM profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALIM (Alimera Sciences Inc.) and more on Quantisnow.